NCT03148444View on ClinicalTrials.gov

Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome

PHASE4UnknownINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

June 1, 2019

Study Completion Date

June 1, 2020

Conditions
Infection, BacterialPacemaker Complication
Interventions
DRUG

cefalexin 500 mg qid or roxithromycin 150 mg bid

antibiotics treatment for five days following implantation of cardiac device

Sponsors
All Listed Sponsors
lead

Kaplan Medical Center

OTHER

NCT03148444 - Impact of Antibiotic Treatment Following Implantation of Cardiac Electronic Device on Patient's Outcome | Biotech Hunter | Biotech Hunter